Cargando…

Novel markers of coronary inflammation in patients with type 2 diabetes

Detalles Bibliográficos
Autores principales:	Andrews, J. P. M., Dweck, M. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417408/ https://www.ncbi.nlm.nih.gov/pubmed/31493293 http://dx.doi.org/10.1007/s12350-019-01866-x

Ejemplares similares

Sedentary time and markers of inflammation in people with newly diagnosed type 2 diabetes
por: Falconer, C.L., et al.
Publicado: (2014)

Diabetes and Heart Failure in Patients With Coronary Disease: Separating Markers From Mediators
por: McGuire, Darren K., et al.
Publicado: (2010)

Special Issue on Metabolism and Metabolite Markers in Type 2 Diabetes
por: Eriksson, Jan W.
Publicado: (2022)

Early Detection of Asymptomatic Coronary Artery Disease in Patients with Type 2 Diabetes Mellitus
por: Youn, Ho-Joong
Publicado: (2009)

Adiposity markers and risk of coronary heart disease in patients with type 2 diabetes mellitus
por: Tonding, Simone F, et al.
Publicado: (2014)

Type 2 Diabetes and Oxidative Stress and Inflammation: Pathophysiological Mechanisms and Possible Therapeutic Options
por: Vassalle, Cristina, et al.
Publicado: (2022)

Platelet Mediated Inflammation in Coronary Artery Disease with Type 2 Diabetes Patients
por: Johny, Ebin, et al.
Publicado: (2021)

Inflammation, Atherosclerosis and Coronary Artery Disease
por: Momiyama, Yukihiko, et al.
Publicado: (2016)

Serum endostatin level as a marker for coronary artery calcification in type 2 diabetic patients
por: El-Ashmawy, Hazem M., et al.
Publicado: (2019)

Relationship between inflammatory markers and coronary slow flow in type 2 diabetic patients
por: Elsanan, Moataz Ali Hasan Ali, et al.
Publicado: (2023)

The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial
por: Gohari, Sepehr, et al.
Publicado: (2022)

Targeting inflammation in type 2 diabetes by antibody-mediated Tyro-3, Axl, Mer receptor activation
por: Lee, Chien-Hsing, et al.
Publicado: (2015)

Inflammation and oxidative stress markers in type 2 diabetes patients with Advanced Carotid atherosclerosis
por: Ménégaut, Louise, et al.
Publicado: (2023)

Strategies to Reduce the Cost of Renal Complications in Patients With Type 2 Diabetes
por: Gilmer, Todd P., et al.
Publicado: (2011)

Markers of Inflammation and Risk of Coronary Heart Disease
por: Sarwar, Nadeem, et al.
Publicado: (2009)

Novel approaches to the treatment of type 1 diabetes
por: Bloomgarden, Zachary
Publicado: (2022)

Markers of Antioxidant Defense in Patients with Type 2 Diabetes
por: Gawlik, K., et al.
Publicado: (2016)

Body composition analysis components as markers for coronary artery diseases in type 2 diabetic patients
por: Dutta, Pritika S., et al.
Publicado: (2021)

Relation of Asymmetric Dimethylarginine Levels to Macrovascular Disease and Inflammation Markers in Type 2 Diabetic Patients
por: Celik, Mustafa, et al.
Publicado: (2014)

Association of inflammation-related markers and diabetic retinopathy severity in the aqueous humor, but not serum of type 2 diabetic patients
por: Saucedo, Lucia, et al.
Publicado: (2023)

Relation of Abdominal Fat Depots to Systemic Markers of Inflammation in Type 2 Diabetes
por: Sam, Susan, et al.
Publicado: (2009)

Atorvastatin lowers (68)Ga-DOTATATE uptake in coronary arteries, bone marrow and spleen in individuals with type 2 diabetes
por: Oostveen, Reindert F., et al.
Publicado: (2023)

Evaluation of Serum Levels of Inflammation, Fibrinolysis and Oxidative Stress Markers in Coronary Artery Disease Prediction: A Cross-Sectional Study
por: Castro, Iran, et al.
Publicado: (2019)

The Efficacy of Vildagliptin in Korean Patients with Type 2 Diabetes
por: Moon, Jun Sung, et al.
Publicado: (2013)

Screening of Autonomic Neuropathy in Patients with Type 2 Diabetes
por: Koo, Bo Kyung
Publicado: (2014)

Using registries to identify type 2 diabetes patients
por: Thomsen, Reimar W, et al.
Publicado: (2014)

Volume Status, a Novel Marker of Contrast Induced Acute Kidney Injury in Acute Heart Failure Undergoing Coronary Angiography?
por: Lee, Sung Woo
Publicado: (2020)

Th17-type immunity and inflammation of aging
por: Merino, Kristen M., et al.
Publicado: (2021)

Genetic Markers of Insulin Resistance and Atherosclerosis in Type 2 Diabetes Mellitus Patients with Coronary Artery Disease
por: Perumalsamy, Sangeetha, et al.
Publicado: (2023)

Quest for pharmacotherapy in aortic valve stenosis: the lipid hypothesis
por: Zheng, Kang H, et al.
Publicado: (2020)

Bone markers and cardiovascular risk in type 2 diabetes patients
por: Zwakenberg, Sabine R., et al.
Publicado: (2018)

Gazing into smoldering volcanoes: precision cardiac imaging
por: Moss, Alastair J, et al.
Publicado: (2018)

Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity
por: Newsome, Philip, et al.
Publicado: (2019)

Does nondiabetic renal disease exacerbate diabetic nephropathy in patients with type 2 diabetes?
por: Park, Cheol Whee
Publicado: (2013)

Dietary Sodium Intake in Patients with Type 2 Diabetes Mellitus
por: Kim, Mi-Kyung
Publicado: (2016)

Drivers of Type 2 Inflammation in Allergic Airway Disease: Wnt You Like to Know?
por: Wu, Xinhui, et al.
Publicado: (2022)

Misdiagnosis of type 1 and type 2 diabetes in adults
por: The Lancet Regional Health – Europe
Publicado: (2023)

Optimizing glucose control for diabetic patients undergoing percutaneous coronary intervention
por: Chang, Haseong, et al.
Publicado: (2021)

Oxidative Stress and Inflammation in Diabetic Complications
por: Vikram, Ajit, et al.
Publicado: (2014)

Diabetic Nephropathy: Proteinuria, Inflammation, and Fibrosis
por: Zheng, Shirong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f0lhq237g3lqahc30sk8o911pi